全文获取类型
收费全文 | 23568篇 |
免费 | 1268篇 |
国内免费 | 162篇 |
学科分类
医药卫生 | 24998篇 |
出版年
2023年 | 175篇 |
2022年 | 245篇 |
2021年 | 735篇 |
2020年 | 409篇 |
2019年 | 498篇 |
2018年 | 671篇 |
2017年 | 461篇 |
2016年 | 620篇 |
2015年 | 595篇 |
2014年 | 813篇 |
2013年 | 938篇 |
2012年 | 1502篇 |
2011年 | 1788篇 |
2010年 | 1002篇 |
2009年 | 878篇 |
2008年 | 1461篇 |
2007年 | 1471篇 |
2006年 | 1446篇 |
2005年 | 1526篇 |
2004年 | 1516篇 |
2003年 | 1414篇 |
2002年 | 1307篇 |
2001年 | 325篇 |
2000年 | 306篇 |
1999年 | 326篇 |
1998年 | 293篇 |
1997年 | 257篇 |
1996年 | 186篇 |
1995年 | 170篇 |
1994年 | 169篇 |
1993年 | 129篇 |
1992年 | 145篇 |
1991年 | 132篇 |
1990年 | 115篇 |
1989年 | 101篇 |
1988年 | 104篇 |
1987年 | 99篇 |
1986年 | 84篇 |
1985年 | 84篇 |
1984年 | 73篇 |
1983年 | 44篇 |
1982年 | 40篇 |
1981年 | 32篇 |
1980年 | 30篇 |
1979年 | 43篇 |
1978年 | 35篇 |
1977年 | 32篇 |
1976年 | 21篇 |
1975年 | 25篇 |
1974年 | 21篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Hitoshi Uchiyama Masayuki Tsujimoto Tadakazu Shinmoto Hitomi Ogino Tomoko Oda Takuya Yoshida Taku Furukubo Satoshi Izumi Tomoyuki Yamakawa Hidehisa Tachiki Tetsuya Minegaki Kohshi Nishiguchi 《Toxins》2014,6(9):2612-2625
The risk of myopathy and rhabdomyolysis is considerably increased in statin users with end-stage renal failure (ESRF). Uremic toxins, which accumulate in patients with ESRF, exert cytotoxic effects that are mediated by various mechanisms. Therefore, accumulation of uremic toxins might increase statin-induced cytotoxicity. The purpose of this study was to determine the effect of four uremic toxins—hippuric acid, 3-carboxy-4-methyl-5-propyl-2-furanpropionate, indole-3-acetic acid, and 3-indoxyl sulfate—on statin-induced myopathy. Differentiated rhabdomyosarcoma cells were pre-treated with the uremic toxins for seven days, and then the cells were treated with pravastatin or simvastatin. Cell viability and apoptosis were assessed by viability assays and flow cytometry. Pre-treatment with uremic toxins increased statin- but not cisplatin-induced cytotoxicity (p < 0.05 vs. untreated). In addition, the pre-treatment increased statin-induced apoptosis, which is one of the cytotoxic factors (p < 0.05 vs. untreated). However, mevalonate, farnesol, and geranylgeraniol reversed the effects of uremic toxins and lowered statin-induced cytotoxicity (p < 0.05 vs. untreated). These results demonstrate that uremic toxins enhance statin-induced apoptosis and cytotoxicity. The mechanism underlying this effect might be associated with small G-protein geranylgeranylation. In conclusion, the increased severity of statin-induced rhabdomyolysis in patients with ESRF is likely due to the accumulation of uremic toxins. 相似文献
992.
Taichi Nishimura Yasuyuki Saito Ken Washio Satomi Komori Datu Respatika Takenori Kotani Yoji Murata Hiroshi Ohnishi Satoshi Mizobuchi Takashi Matozaki 《European journal of immunology》2020,50(10):1560-1570
Signal regulatory protein α (SIRPα) is expressed predominantly on type 2 conventional dendritic cells (cDC2s) and macrophages. We previously showed that mice systemically lacking SIRPα were resistant to experimental autoimmune encephalomyelitis (EAE). Here, we showed that deletion of SIRPα in CD11c+ cells of mice (SirpaΔDC mice) also markedly ameliorated the development of EAE. The frequency of cDCs and migratory DCs (mDCs), as well as that of Th17 cells, were significantly reduced in draining lymph nodes of SirpaΔDC mice at the onset of EAE. In addition, we found the marked reduction in the number of Th17 cells and DCs in the CNS of SirpaΔDC mice at the peak of EAE. Whereas inducible systemic ablation of SIRPα before the induction of EAE prevented disease development, that after EAE onset did not ameliorate the clinical signs of disease. We also found that EAE development was partially attenuated in mice with CD11c+ cell-specific ablation of CD47, a ligand of SIRPα. Collectively, our results suggest that SIRPα expressed on CD11c+ cells, such as cDC2s and mDCs, is indispensable for the development of EAE, being required for the priming of self-reactive Th17 cells in the periphery as well as for the inflammation in the CNS. 相似文献
993.
Yoshihito Uchida Masamitsu Nakao Shohei Tsuji Hayato Uemura Jun-ichi Kouyama Kayoko Naiki Daisuke Motoya Kayoko Sugawara Nobuaki Nakayama Yukinori Imai Tomoaki Tomiya Satoshi Mochida 《Journal of medical virology》2020,92(3):329-338
The significance of switching of the nucleos(t)ide analog used to treat patients with hepatitis B virus (HBV) from entecavir (ETV) to tenofovir alafenamide fumarate (TAF) is uncertain. The subjects of this study were 159 patients with HBV who received treatment with ETV followed by TAF. Among these patients, serial changes in the HBV marker levels were monitored in 92 patients in whom the serum HBsAg levels were ≥100 IU/mL during the 48-week period immediately before and after the switching. A questionnaire survey for medication compliance was performed in 127 patients. The serum HBsAg levels (log IU/mL) decreased by 0.041 during the ETV treatment period and by 0.068 during the TAF administration period. The degree of reduction was higher during the TAF administration period than during the ETV administration period in patients without cirrhosis (P = .030), patients with genotype B HBV (P = .014), and patients with undetectable serum HBcrAg (P = .038). Multivariate analysis revealed the HBV genotype (B vs C; odds ratio, 3.400; P = .025) and serum aspartate aminotransferase level (every 1+; 1.111; P = .015) at the time of switching as factors influencing the treatment efficacy. Thirty-six patients (28%) responded that the number of days that they forgot to take the drug decreased after the drug switching, and 77 patients (61%) reported feeling satisfied with the drug switching. Switching of the nucleos(t)ide analog used from ETV to TAF may be useful in the treatment of patients with HBV infection, as it is associated with both a decrease in the serum HBsAg level and improvement of the medication compliance. 相似文献
994.
995.
Ratana Tacharoenmuang Satoshi Komoto Ratigorn Guntapong Sompong Upachai Phakapun Singchai Tomihiko Ide Saori Fukuda Kriangsak Ruchusatsawast Busarawan Sriwantana Masashi Tatsumi Kazushi Motomura Naokazu Takeda Takayuki Murata Somchai Sangkitporn Koki Taniguchi Tetsushi Yoshikawa 《Journal of medical virology》2020,92(2):174-186
Group A rotavirus (RVA) is a major cause of acute gastroenteritis in infants and young children worldwide. This study aims to clarify the distribution of G/P types and genetic characteristics of RVAs circulating in Thailand. Between January 2014 and September 2016, 1867 stool specimens were collected from children and adults with acute gastroenteritis in six provinces in Thailand. RVAs were detected in 514/1867 (27.5%) stool specimens. G1P[8] (44.7%) was the most predominant genotype, followed by G3P[8] (33.7%), G2P[4] (11.5%), G8P[8] (7.0%), and G9P[8] (1.3%). Unusual G3P[9] (0.8%), G3P[10] (0.4%), G4P[6] (0.4%), and G10P[14] (0.2%) were also detected at low frequencies. The predominant genotype, G1P[8] (64.4%), in 2014 decreased to 6.1% in 2016. In contrast, the frequency of G3P[8] markedly increased from 5.5% in 2014 to 65.3% in 2015 and 89.8% in 2016. On polyacrylamide gel electrophoresis, most (135/140; 96.4%) of the G3P[8] strains exhibited a short RNA profile. Successful determination of the nucleotide sequences of the VP7 genes of 98 G3P[8] strains with a short RNA profile showed that they are all equine-like G3P[8] strains. On phylogenetic analysis of genome segments of two representative Thai equine-like G3P[8] strains, it was noteworthy that they possessed distinct NSP4 genes, one bovine-like and the other human-like. Thus, we found that characteristic equine-like G3P[8] strains with a short RNA electropherotype are becoming highly prevalent in children and adults in Thailand. 相似文献
996.
Midori Iida Miyuki Suzuki Yuto Sakane Hiroyo Nishide Ikuo Uchiyama Takashi Yamamoto Ken‐ichi T. Suzuki Satoshi Fujii 《Genes to cells : devoted to molecular & cellular mechanisms》2020,25(7):498-509
Founder animals carrying high proportions of somatic mutation induced by CRISPR–Cas9 enable a rapid and scalable strategy for the functional screening of numerous target genes in vivo. In this functional screening, genotyping using pooled amplicons with next‐generation sequencing is the most suitable approach for large‐scale management of multiple samples and accurate evaluation of the efficiency of Cas9‐induced somatic mutations at target sites. Here, we present a simple workflow for genotyping of multiple CRISPR–Cas9‐based knockout founders by pooled amplicon sequencing. Using custom barcoded primers, pooled amplicons from multiple individuals can be run in a single‐indexed library on the Illumina MiSeq platform. Additionally, a user‐friendly web tool, CLiCKAR, is available to simultaneously perform demultiplexing of pooled sequence data and evaluation of somatic mutation in each phenotype. CLiCKAR provides users with practical reports regarding the positions of insertions/deletions, as well as the frameshift ratio and tables containing mutation sequences, and read counts of each phenotype, with just a few clicks by the implementation of demultiplexing for pooled sample data and calculation of the frameshift ratio. This genotyping workflow can be harnessed to evaluate genotype–phenotype correlations in CRISPR–Cas9‐based loss‐of‐function screening of numerous target genes in various organisms. 相似文献
997.
Erika Ishihara Yuya Nagaoka Toshiaki Okuno Satoshi Kofuji Mari Ishigami‐Yuasa Hiroyuki Kagechika Kenya Kamimura Shuji Terai Takehiko Yokomizo Yukihiko Sugimoto Yasuyuki Fujita Akira Suzuki Hiroshi Nishina 《Genes to cells : devoted to molecular & cellular mechanisms》2020,25(3):197-214
Cell competition is a biological process by which unfit cells are eliminated from “cell society.” We previously showed that cultured mammalian epithelial Madin‐Darby canine kidney (MDCK) cells expressing constitutively active YAP were eliminated by apical extrusion when surrounded by “normal” MDCK cells. However, the molecular mechanism underlying the elimination of active YAP‐expressing cells was unknown. Here, we used high‐throughput chemical compound screening to identify cyclooxygenase‐2 (COX‐2) as a key molecule triggering cell competition. Our work shows that COX‐2‐mediated PGE2 secretion engages its receptor EP2 on abnormal and nearby normal cells. This engagement of EP2 triggers downstream signaling via an adenylyl cyclase‐cyclic AMP‐PKA pathway that, in the presence of active YAP, induces E‐cadherin internalization leading to apical extrusion. Thus, COX‐2‐induced PGE2 appears a warning signal to both abnormal and surrounding normal cells to drive cell competition. 相似文献
998.
999.
Michinori Funato Osamu Uemura Katsumi Ushijima Hidenori Ohnishi Kenji Orii Zenichiro Kato Satoshi Yamakawa Takuhito Nagai Osamu Ohara Hideo Kaneko Naomi Kondo 《Journal of clinical immunology》2014,34(6):691-695
Purpose
Gain-of-function mutations in complement factor B (CFB) were recently identified in patients with atypical hemolytic uremic syndrome (aHUS), but are extremely rare. Our purpose is to describe a large kindred with aHUS associated with a CFB mutation and to further understand CFB-mutated aHUS patients.Methods and Results
We report a large kindred in which 3 members had aHUS. This kindred revealed that 9 of 12 members, including 2 affected patients, had persistent activation of the alternative pathway with low complement component 3 and that those 9 members showed a CFB mutation (c.1050G?>?C, p.Lys350Asn) in exon 8. This missense mutation was heterozygous in 8 of them and homozygous in only one. From structural studies, this mutation is shown to be located in close proximity to the Mg2-binding site within a von Willebrand factor type A domain of CFB, resulting in a gain-of-function effect of CFB and predisposition to aHUS. At present, 2 of the 3 members with aHUS have maintained normal renal function for a long-term period.Conclusions
This kindred illustrates that a CFB mutation (c.1050G?>?C, p.Lys350Asn) can result in aHUS. In the future, phenotype-genotype correlations and outcome in CFB-mutated aHUS patients need to be further investigated by accumulation of a number of cases. 相似文献1000.
Hiromi Kubagawa Satoshi Oka Yoshiki Kubagawa Ikuko Torii Eiji Takayama Dong-Won Kang Dewitt Jones Naonori Nishida Toshio Miyawaki Luigi F. Bertoli Sheila K. Sanders Kazuhito Honjo 《Journal of clinical immunology》2014,34(1):35-45
IgM exists as both a monomer on the surface of B cells and a pentamer secreted by plasma cells. Both pre-immune “natural” and antigen-induced “immune” IgM antibodies are important for protective immunity and for immune regulation of autoimmune processes by recognizing pathogens and self-antigens. Effector proteins interacting with the Fc portion of IgM, such as complement and complement receptors, have thus far been proposed but fail to fully account for the IgM-mediated protection and regulation. A major reason for this deficit in our understanding of IgM function seems to be lack of data on a long elusive Fc receptor for IgM (FcμR). We have recently identified a bona fide FcμR in both humans and mice. In this article we briefly review what we have learned so far about FcμR. 相似文献